Near-fatal asthma phenotype in the ENFUMOSA cohort

Clinical and Experimental Allergy

Volumn 37, Issue 4, 2007, Pages 552-557

  Romagnoli, M ^a,b,g   Caramori, G ^a   Braccioni, F ^a   Ravenna, F ^a   Barreiro, E ^c,g   Siafakas, N M ^d,g   Vignola, A M ^e,g   Chanez, P ^f,g   Fabbri, L M ^a,b,g   Papi, A ^a,g   Abraham, B ^g   Anto J M ^g   Bel, E H D ^g   Bonsignore, G ^g   Bousquet, J ^g   Castellsague, J ^g   Cibella, F ^g   Cuttitta, G ^g   Dahlen B ^g   Dahlen S E ^g   Drews, N ^g   Djukanovic, R ^g   Folkerts, G ^g   Gaga, M ^g   Gratziou, C ^g   Guerrera, G ^g   Holgate, S T ^g   Howarth, P H ^g   Johnston, S L ^g   Kanniess, F ^g   Kips, J C ^g   Kerstjens, H A M ^g   Kumlin, M ^g   Magnussen, H ^g   Nijkamp, F P ^g   Papageorgiou, N ^g   Postma, D S ^g   Pauwels, R A ^g   Rabe, K F ^g   Richter, K ^g   Roldaan, A C ^g   Roquet, A ^g   Sanjuas, C ^g   Timens, W ^g   Tzanakis, N ^g   Vachier, I ^g   Watson, L ^g   Yourgioti, G ^g   more..

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d UNIVERSITY OF CRETE   (Greece)

^e UNIVERSITY OF PALERMO   (Italy)

^f MONTPELLIER UNIVERSITY HOSPITAL   (France)

^g NONE

Author keywords

Inflammation; Near fatal asthma; Severe asthma; Sputum

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; PREDNISONE; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; ATOPY; BLOOD GAS ANALYSIS; CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATORY CELL; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NEAR FATAL ASTHMA; PATIENT COMPLIANCE; PHENOTYPE; PRIORITY JOURNAL; SPUTUM ANALYSIS;

EID: 34047198677     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02683.x     Document Type: Article

References (21)

1. McFadden ER Jr. Acute severe asthma. Am J Respir Crit Care Med 2003; 168:740-59.
2. Dhuper S, Maggiore D, Chung V, Shim C. Profile of near-fatal asthma in an inner-city hospital. Chest 2003; 124:1880-4.
3. McFadden ER Jr, elSanadi N, Strauss L et al. The influence of parasympatholytics on the resolution of acute attacks of asthma. Am J Med 1997; 102:7-13.
4. Rodrigo GJ, Rodrigo C, Nannini LJ. Fatal or near-fatal asthma: clinical entity or incorrect management? Arch Bronconeumol 2004; 40:24-33.
5. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest 2004; 125:1081-102.
6. Martinez-Moragon E, Plaza V, Serrano J et al. Near-fatal asthma related to menstruation. J Allergy Clin Immunol 2004; 113:242-4.
7. Turner MO, Noertjojo K, Vedal S, Bai T, Crump S, Fitzgerald JM. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med 1998; 157:1804-9.
8. Boulet LP, Deschesnes F, Turcotte H, Gignac F. Near-fatal asthma: clinical and physiologic features, perception of bronchoconstriction, and psychologic profile. J Allergy Clin Immunol 1991; 88:838-46.
9. Alvarez GG, Schulzer M, Jung D, Fitzgerald JM. A systematic review of risk factors associated with near-fatal and fatal asthma. Can Respir J 2005; 12:265-70.
10. Barreiro E, Gea J, Sanjuas C, Marcos R, Broquetas J, Milic-Emili J. Dyspnoea at rest and at the end of different exercises in patients with near-fatal asthma. Eur Respir J 2004; 24:219-25.
11. de Klerk A, van Schalkwyk E, Williams Z, Lee W, Bardin P. Risk factors for near-fatal asthma - a case-control study in a Western Cape teaching hospital. S Afr Med J 2002; 92:140-4.
12. Gelb AF, Schein A, Nussbaum E et al. Risk factors for near-fatal asthma. Chest 2004; 126:1138-46.
13. Plaza V, Serrano J, Picado C, Sanchis J. Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma. Eur Respir J 2002; 19:846-52.
14. Romero-Frais E, Vazquez MI, Sandez E, Blanco-Aparicio M, Otero I, Verea H. Prescription of oral corticosteroids in near-fatal asthma patients: relationship with panic-fear, anxiety and depression. Scand J Psychol 2005; 46:459-65.
15. Yoshimine F, Hasegawa T, Suzuki E et al. Contribution of aspirin-intolerant asthma to near fatal asthma based on a questionnaire survey in Niigata Prefecture, Japan. Respirology 2005; 10:477-84.
16. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma European network for Understanding Mechanisms of Severe Asthma. Eur Respir J 2003; 22:470-7.
17. Redier H, Daures JP, Michel C et al. Assessment of the severity of asthma by an expert system. Description and evaluation. Am J Respir Crit Care Med 1995; 151:345-52.
18. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J 1993; 16 (Suppl.):5-40.
19. Lemanske RF Jr, Sorkness CA, Mauger EA et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. J Am Med Assoc 2001; 285:2594-603.
20. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343:332-6.
21. Glassroth J. The role of long-acting beta-agonists in the management of asthma: analysis, meta-analysis, and more analysis. Ann Intern Med 2006; 144:936-7.